American Society of Clinical Oncology (ASCO)

While today’s announcement is a step in the right direction to meet the learning needs of today’s busy, specialized oncologist, there's a lot more to be done to improve the recertification process and resources, including expanding the scope of disease-focused LKAs. 

The use of #AI was a central theme at this year's ASCO Annual Meeting, especially large language models like ChatGPT. Yet despite the promising future of many AI tools already used by oncologists, there are still challenges that necessitate caution, such as limited data sets and the potential to amplify existing disparities. In this ASCO Daily News look back at the top #ASCO24 research on AI, a team of authors revisits several key studies and highlights the growing need for safe and trustworthy tools that can improve patient outcomes: https://brnw.ch/21wPypY

Applications are open for an interactive clinical research course we’re hosting with AIOM | Associazione Italiana di Oncologia Medica in Rome next spring. The International Clinical Research Course (ICRC) will be held March 14-15 and is aimed at beginning investigators who would like to learn more about how to organize research, use clinical research methodologies, assess the quality of published research and its impact on evidence-based medicine, formulate a research question, and use tools to assess protocols. Applications are due January 31 at 11:59 p.m. (ET), and applicants will be notified by mid-February. Apply today: https://brnw.ch/21wPwP7

Congratulations to Elizabeth A. Mittendorf, MD, PhD, MHCM, FASCO on being elected to serve as ASCO President for the 2026-2027 term! Dr. Mittendorf will take office as President-Elect after the #ASCO25 Annual Business Meeting on June 2, 2025. Six additional members were elected to positions on the ASCO Board of Directors and Nominating Committee. Read the full announcement: https://brnw.ch/21wPuRW

Thank you OncoDaily for highlighting the work City Cancer Challenge did with Nairobi stakeholders in collaboration with American Society of Clinical Oncology (ASCO) and the National Cancer Institute of Kenya. The two day training on multidisciplinary Cancer Management Course brought to light; *The importance of Multidisciplinary care in management of cancer cases * The various health care providers that need to be involved in the Multidisciplinary Teams *The efficiency required in planning and executing multidisciplinary team meetings We had very rich discussions on how multidisciplinary care can enhance quality cancer care. Julie Gralow Anees Chagpar Rolando Camacho DR. ELIAS MELLY, M.D Miriam Mutebi, MD,MSc,FACS Abeid M. Athman Omar Mohammed Ezzi Angela McLigeyo Manel Haj Mansour Sitna Ali Mwanzi Dr Lucas K Nyabero Prof Muthoni Musibi Dr. Esther Nafula Roselyne Okumu Sophie Bussmann-Kemdjo Isabel Mestres Suzanne Silantoi. L

Exciting news! Our CDK Study has enrolled its first patient at Ironwood Cancer and Research Centers, and patient enrollment also has opened at Miami Cancer Institute at Baptist Health South Florida and three St. Joseph's/Candler locations, including Savannah, Georgia; Bluffton, South Carolina; and Hilton Head Island, South Carolina. This study is comparing two personalized dosing strategies for CDK4/6 inhibitors in older adults with metastatic #BreastCancer. The trial compares the efficacy and tolerability of a titrated dosing approach to the standard FDA-approved dosing. By starting with a lower dose and gradually increasing it as tolerated, the CDK Study aims to minimize side effects and improve treatment outcomes. The findings of the CDK Study have the potential to inform clinical practice guidelines and could lead to new standards of care for older adults with metastatic breast cancer. 🤝 This important work is a collaboration between dedicated experts and advocates, including: Julie Gralow, Elizabeth Garrett-Mayer, PhD, FSCT, Pam Mangat-Dhaliwal, and Janice Cowden and funded by Patient-Centered Outcomes Research Institute (PCORI). Learn more about the CDK Study: https://brnw.ch/21wPuJQ #PatientCenteredCare #clinicaltrials #oncology

Registration for the 2025 ASCO Annual Meeting is officially open! Don’t miss the chance to join oncology professionals from around the world for 5 days of collaboration, cutting-edge science, and professional growth. Be at the forefront of advancing cancer care—reserve your spot and hotel today: https://brnw.ch/21wPuAT #ASCO25

Exciting news—#GI25 abstract titles have been released! Explore the groundbreaking research featured at next month’s meeting and start building your plan for engaging with the latest science. Access the titles here: https://shorturl.at/ktIQR Co-Sponsored by: American Gastroenterological Association (AGA), American Society for Radiation Oncology (ASTRO), Society of Surgical Oncology

Check out our new clinical insights on Systemic Therapy for Stage I-III Anal Squamous Cell Carcinoma. Learn more: https://brnw.ch/21wPsfv

Check out our new guideline, Systemic Therapy for Stage I-III Anal Squamous Cell Carcinoma Guideline. Read more: https://brnw.ch/21wPsfm